The bill, titled the "Prescription Pricing for the People Act of 2025," directs the Federal Trade Commission (FTC) to study intermediaries in the pharmaceutical supply chain, like pharmacy benefit managers. The FTC must look into the pricing practices and competitive behavior of these...
Simple Explanation
The bill wants the government to look closely at how companies that help with medicine prices are doing their job and find ways to make medicine cheaper and fairer for people to buy. It asks for a report to tell Congress how to make this better with some rules.